CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1

CUSIP: 189464AB6

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Debt / NOTE 2.500% 9/1
Market price (% of par)
116.31%
Total 13F principal
$247,786,002
Principal change
-$3,847,003
Total reported market value
$288,785,002
Number of holders
29
Value change
-$7,068,157
Number of buys
12
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 189464AB6?
CUSIP 189464AB6 identifies 189464AB6 - CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 as of Q1 2018

As of 31 Mar 2018, CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 was held by 29 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $247,786,002 in principal (par value) of the bond. The largest 10 bondholders included Linden Advisors LP, D. E. Shaw & Co., Inc., Allianz Asset Management GmbH, ZAZOVE ASSOCIATES LLC, CREDIT SUISSE AG/, ADVENT CAPITAL MANAGEMENT /DE/, AMERIPRISE FINANCIAL INC, PUTNAM INVESTMENTS LLC, LORD, ABBETT & CO. LLC, and CAPSTONE INVESTMENT ADVISORS, LLC. This page lists 29 institutional bondholders reporting positions for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.